Top News: Genetic Technologies Limited (NASDAQ:GENE), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Sovran Self Storage Inc. (NYSE:SSS), Evercore Partners Inc. (NYSE:EVR), MagnaChip Semiconductor (NYSE:MX)

Genetic Technologies Limited (NASDAQ:GENE) is a $9.9 million organization. That pales – considerably – in comparison to $1.15 billion Genomic Health, and is downright dwarfed by $2.8 billion Myriad Genetics. That small size alone is alarming to newcomers – never even mind the fact that GENE shares have fallen 73% over the past twelve months. As they say, though, nothing lasts forever, and it looks … Continue reading Top News: Genetic Technologies Limited (NASDAQ:GENE), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Sovran Self Storage Inc. (NYSE:SSS), Evercore Partners Inc. (NYSE:EVR), MagnaChip Semiconductor (NYSE:MX)

Active Watch List : Bank of America Corporation (NYSE:BAC), Wells Fargo (NYSE:WFC), Kongzhong Corp. (NASDAQ:KZ), ConAgra Foods, Inc. (NYSE:CAG), Genetic (NASDAQ:GENE)

Last December Bank of America Corporation (NYSE:BAC) sold the Dunbar mortgage together with other mortgages to US Acquisition Property XXXVII LLC, an arm of Republic Financial. To add to the confusion, Republic recently put up the mortgage as collateral in a deal with Pacific Western Bank of Los Angeles, but records indicate that Republic is still the official holder. TheAdvocate reached Republic by telephone and was … Continue reading Active Watch List : Bank of America Corporation (NYSE:BAC), Wells Fargo (NYSE:WFC), Kongzhong Corp. (NASDAQ:KZ), ConAgra Foods, Inc. (NYSE:CAG), Genetic (NASDAQ:GENE)

Canadian Solar Inc. (NASDAQ:CSIQ) on July 7th, 2014 announced that its wholly owned subsidiary, Canadian Solar Solutions Inc., on June 30th, completed the sale of the 10 MW AC solar photovoltaic (PV) power plant “Val Caron” valued at over CAD 60 million to One West Holdings Ltd., an affiliate of Concord Green Energy. Canadian Solar Inc. (NASDAQ:CSIQ) stock performance was -3.19% in last session and finished … Continue reading Volatile Stocks: Canadian Solar (NASDAQ:CSIQ), Genetic Technologies (NASDAQ:GENE), Dendreon (NASDAQ:DNDN), Arena Pharmaceuticals (NASDAQ:ARNA)

Aldeyra Therapeutics Inc (NASDAQ:ALDX) Director C. Boyd Clarke purchased 12,500 shares of the stock in a transaction dated Wednesday, May 7th. The stock was purchased at an average price of $8.00 per share, with a total value of $100,000.00. Following the acquisition, the director now directly owns 12,500 shares in the company, valued at approximately $100,000. Aldeyra Therapeutics Inc (NASDAQ:ALDX) stock performance was -8.31% in … Continue reading Biotech decliners: Aldeyra Therapeutics Inc (NASDAQ:ALDX), Uniqure NV (NASDAQ:QURE), Regulus Therapeutics Inc (NASDAQ:RGLS), Genetic Technologies Limited (ADR) (NASDAQ:GENE)